Karlén P - Search Results

1

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.

Lindberg A, Eberhardson M, Karlsson M, Karlén P. Lindberg A, et al. Among authors: karlen p. BMC Gastroenterol. 2010 Jul 6;10:73. doi: 10.1186/1471-230X-10-73. BMC Gastroenterol. 2010. PMID: 20604939 Free PMC article.

2

DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia.

Löfberg R, Broström O, Karlén P, Ost A, Tribukait B. Löfberg R, et al. Among authors: karlen p. Gastroenterology. 1992 Apr;102(4 Pt 1):1149-54. Gastroenterology. 1992. PMID: 1551524

3

Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study.

Löfberg R, Broström O, Karlén P, Tribukait B, Ost A. Löfberg R, et al. Among authors: karlen p. Gastroenterology. 1990 Oct;99(4):1021-31. doi: 10.1016/0016-5085(90)90622-8. Gastroenterology. 1990. PMID: 2394325

4

Crohn's disease and cancer: a population-based cohort study.

Persson PG, Karlén P, Bernell O, Leijonmarck CE, Broström O, Ahlbom A, Hellers G. Persson PG, et al. Among authors: karlen p. Gastroenterology. 1994 Dec;107(6):1675-9. doi: 10.1016/0016-5085(94)90807-9. Gastroenterology. 1994. PMID: 7958678

5

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study.

Karlén P, Kornfeld D, Broström O, Löfberg R, Persson PG, Ekbom A. Karlén P, et al. Gut. 1998 May;42(5):711-4. doi: 10.1136/gut.42.5.711. Gut. 1998. PMID: 9659169 Free PMC article.

6

Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy.

Karlén P, Young E, Broström O, Löfberg R, Tribukait B, Ost K, Bodian C, Itzkowitz S. Karlén P, et al. Gastroenterology. 1998 Dec;115(6):1395-404. doi: 10.1016/s0016-5085(98)70018-6. Gastroenterology. 1998. PMID: 9834267

7

Increased risk of cancer in ulcerative colitis: a population-based cohort study.

Karlén P, Löfberg R, Broström O, Leijonmarck CE, Hellers G, Persson PG. Karlén P, et al. Am J Gastroenterol. 1999 Apr;94(4):1047-52. doi: 10.1111/j.1572-0241.1999.01012.x. Am J Gastroenterol. 1999. PMID: 10201481

8

Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.

Askling J, Dickman PW, Karlén P, Broström O, Lapidus A, Löfberg R, Ekbom A. Askling J, et al. Among authors: karlen p. Lancet. 2001 Jan 27;357(9252):262-6. doi: 10.1016/S0140-6736(00)03612-6. Lancet. 2001. PMID: 11214128

9

Family history as a risk factor for colorectal cancer in inflammatory bowel disease.

Askling J, Dickman PW, Karlén P, Broström O, Lapidus A, Löfberg R, Ekbom A. Askling J, et al. Among authors: karlen p. Gastroenterology. 2001 May;120(6):1356-62. doi: 10.1053/gast.2001.24052. Gastroenterology. 2001. PMID: 11313305

10

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County.

Ljung T, Karlén P, Schmidt D, Hellström PM, Lapidus A, Janczewska I, Sjöqvist U, Löfberg R. Ljung T, et al. Among authors: karlen p. Gut. 2004 Jun;53(6):849-53. doi: 10.1136/gut.2003.018515. Gut. 2004. PMID: 15138212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results